ERVMER34-1

Model summary

A human Env-like fusogenic polyprotein that is synthesized as a single chain and proteolytically matured into a receptor-binding surface module and a membrane-anchored fusion module. By binding a cell-surface determinant and assembling into a trimeric hairpin, it catalyzes membrane merger required for myoblast fusion and formation of multinucleated myotubes. The complex traffics through intracellular membrane systems en route to sites of fusion, where receptor engagement triggers controlled pore formation and syncytium development.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture: IPR018154 (TLV/ENV coat polyprotein family) spans residues 23–508, covering essentially the entire polypeptide.

   This family signature defines a retroviral envelope polyprotein that is synthesized as a single chain and then proteolytically cleaved into two functional modules: an N-terminal surface (SU) domain that mediates receptor binding and a C-terminal transmembrane (TM) domain that executes membrane fusion. The near-full-length coverage indicates that the sequence encodes both the receptor-binding ectodomain and the fusogenic TM region within one precursor, a canonical Env architecture. Such an arrangement causes a two-step mechanism: SU confers high-affinity protein binding, while TM forms a fusion-active module that assembles into a trimeric hairpin to drive bilayer merger.

2. 02

   From this architecture, the molecular function resolves first as protein binding (GO:0005515).

   The SU domain’s role is to recognize and bind a host surface molecule, positioning the TM domain for catalysis of membrane merger. The absence of enzymatic motifs and the dominance of binding/fusogenic features reinforce that binding is the primary measurable activity.

3. 03

   This binding-triggered fusogenic mechanism naturally feeds into myoblast fusion (GO:0007520).

   In skeletal muscle development, myoblasts must fuse to form multinucleated myotubes. An Env-derived fusogen provides precisely the membrane-merger chemistry required for this syncytium formation. The SU–TM division ensures that receptor engagement on adjacent myoblasts nucleates local membrane curvature and fusion pore formation, directly executing the fusion step.

4. 04

   Cellular localization follows from the polyprotein’s lifecycle and topology.

   The TM domain embeds the fusogenic core in membranes, placing the protein in intracellular membrane-bounded organelles (GO:0043231) during biosynthesis and trafficking through the secretory pathway. The SU domain can be secreted or luminal, while the TM region anchors the complex to endomembranes and later to the cell surface. This trafficking path is typical for Env-like fusogens that assemble in the ER–Golgi route before reaching sites of fusion.

5. 05

   Mechanistically, I hypothesize that the SU domain binds a specific cell-surface determinant to concentrate the fusogen at myoblast contact zones.

   Proteolytic maturation yields a trimeric TM assembly that refolds to drive lipid mixing. Likely interaction partners include a myoblast-surface adhesion or receptor molecule that licenses fusion, as well as intracellular trafficking and fusogenic cofactors that chaperone assembly and activation. Together, these interactions channel receptor binding into controlled membrane fusion that builds multinucleated muscle fibers.